Two assessments. The laser assessment can be completed with staff or handed to the patient to answer on their own.
www.drmkhealth.com · 212-257-2777
Laser Consultation Assessment
Welcome! 👋
This short questionnaire helps us plan your laser treatment safely. You can answer on your own, or our staff will complete it with you. There are two steps:
☀️Step 1 — About your skin & sun10 quick multiple-choice questions. There are no wrong answers — just pick what best describes you.
💊Step 2 — Medications & historyTap anything you currently take or use. This helps us keep your treatment safe and comfortable.
Your answers stay on this device and will be reviewed with you by our staff.
Laser Consultation Assessment
About your treatment
Tap all that apply — our staff can adjust this with you later.
Patient information (optional)
Which area are we treating?
Which treatment are you interested in?
Question 1
Step 2 of 2 · Medications & history
Do any of these apply to you right now?
Tap everything you currently take, use, or that applies to you. Tap again to unselect. If nothing applies, just continue.
🎉
All done — thank you!
Please hand the device back to our staff. We'll review your results together.
Staff Access
Enter staff PIN
Results and recommendations are visible to our team only.
Assessment Summary · Laser Consultation
Assessment results
Fitzpatrick type
Fitzpatrick questionnaire (0–40)
IIIIIIIVVVI
Sunburn risk
Post-laser pigment risk
⚠️ Reported medications & history
Laser considerations for this type
🔬 Device notes for selected treatments
⚙️ Suggested starting settings for this patient
🛍️ Recommended pre & post-treatment products
Starting-point suggestions from our iS Clinical, Neova, and Alastin lines — final regimen is tailored by our staff to your treatment plan.
📊 Usage (this device)
✔ Staff verification
Self-reported screening for planning purposes — verify medications and history verbally, and confirm Fitzpatrick type on clinical examination. This estimate is not a clearance or diagnosis, and must never be used to select laser energy settings — device labeling, in-person examination, and a test spot govern. Device choice and settings remain the provider's clinical decision.
Patient File Report
Fill in the patient details (optional — they appear in the report header), then print or save as PDF for the chart.
Self-reported screening questionnaire completed in office. Fitzpatrick type is an estimate based on questionnaire scoring and should be confirmed on clinical examination. Medications and history must be verified verbally. This estimate is not a clearance, diagnosis, or treatment setting — it must never be used to select laser energy settings; device labeling, in-person examination, and a test spot govern. Device selection, wavelengths, and treatment settings remain the clinical decision of the treating provider. Product recommendations are a starting point and are tailored by staff.
Patient attestation
I confirm that the information provided in this questionnaire is accurate and complete, and that I am able and willing to follow the aftercare instructions provided. · Confirmo que la información proporcionada en este cuestionario es correcta y completa, y que puedo y estoy dispuesto(a) a seguir las instrucciones de cuidado posterior.
Patient signature & date / Firma del paciente y fecha
Reviewing provider signature & date
Your skin type
Care tips for you
🛍️ Our product picks for you
Suggestions from our iS Clinical, Neova, and Alastin lines — ask our staff to tailor a full regimen for you.
This quiz is for general guidance only and isn't medical advice. For persistent skin concerns, consult a dermatologist.
www.drmkhealth.com · 212-257-2777
Your Skin Care Plan
Your skin type
Care tips
Your recommended regimen
Scan to book your treatment · Escanee para reservar su cita — blvd.app/@drmkhealth
Key safety limits: No Advanced-tier settings are published for Fitzpatrick IV–VI — Moderate (8 mJ face / 6 mJ body) is the published ceiling. Pigmented lesion and actinic keratosis protocols are published for Fitzpatrick I–III only. Topical anesthetic is recommended at 10 mJ and above — fully remove and cleanse before lasing.
1. General resurfacing, coagulation of soft tissue & pigment
2. Actinic keratosis (Fitzpatrick I–III only)
3. Additional treatment protocols
4. Percent coverage per pass — by tip & function
Calculating passes: Passes = Coverage Goal ÷ % Coverage per Pass, rounded UP. Examples: 20% goal, Rollers/Random at 15 mJ → 20 ÷ 4.3 = 4.7 → 5 passes. 15% goal, C5/Static 144 at 15 mJ → 15 ÷ 15.5 = 0.97 → 1 pass. The touchscreen displays live % coverage per pass for the current settings — confirm against this table.
Technique
Complete all passes for one anatomical area before moving to the next (left cheek, right cheek, nose/upper lip/chin, forehead). Each pass across the skin counts as a single pass. Apply half the passes in one direction and half in the opposite direction to create a cross-hatch pattern. Use minimal overlap — up to 20% — between rows. Do not treat over the hairline, eyebrows, or beard. Treat clean, dry skin only; use a Zimmer chiller for comfort.
Protocol & endpoints
Test spots are advised for every patient. Set the device to Advance mode for the indications above. Endpoint: erythema, with or without mild-to-moderate edema. Reduce parameters if severe erythema appears or the patient reports severe pain. Expect a burning sensation for 1–2 hours post-treatment; apply post-cooling or a cold compress. Crusting typically sheds within about 7 days. 3 sessions at 3–4 week intervals; 3–4 sessions for actinic keratosis with evaluation after each. For Fitzpatrick IV–VI, consider hydroquinone and daily SPF for 2 weeks before and after to reduce PIH risk.
Internal staff reference — not a substitute for the Operator's Manual (P/N 4100175500) or physician judgment. Final settings are always the treating provider's decision after in-person examination and a test spot.
Test spots & safety: Test spots on every patient at every visit, on the darkest area of the planned site. Start 10–20% below the intended setting. Read at 15–30 min for FST I–III; wait 48–72 hours for FST IV–VI. Ask about hereditary ethnicity and treat to the darkest skin type. Stop immediately for graying/whitening, dark red or purple colour change, blistering, crusting, or intolerable pain. Do not exceed 20 ms ICD pulse duration; set ICD pre-cooling equal to delay — a longer delay at ≥ 90–100 J/cm² on 1064 nm risks sparking and burns. Do not treat patients with pacemakers, cardioverters, or other implanted devices.
Hair removal rules: ICD for all hair removal: 20 / 10 / 0 ms. Endpoint: perifollicular edema and erythema. FST I–III use 755 nm; FST IV–VI use 1064 nm. Do not treat tanned skin — 755 nm requires 4 weeks without sun or self-tanner; 1064 nm requires 1 week. Higher fluence with medium spots for lighter or sparse hair; lower fluence with larger spots for darker or dense hair. Longer pulse widths for coarser hair and darker skin types. 1–2 ms pulse widths are for fine, light hair only — reserve for FST I–II once 75%+ reduction is achieved. If no endpoint, raise fluence by ≈ 2 J/cm². Intervals: face / bikini / arms / underarms 4–6 weeks; back / legs 8–10 weeks.
3. Vascular lesions — 1064 nm (Fitzpatrick I–IV, vessels up to 1.5 mm)
Target skin surface 42–44 °C · ≈ 2000–3000 total pulses · 3–4 week intervals · 3–5 sessions.
Technique & endpoints
Cleanse with a gentle cleanser, wipe with 70% isopropyl alcohol, allow to dry; area must be shaved. IntelliTrak tip: 18% overlap recommended. Stamping: no more than 20% overlap between pulses. Vascular: trace vessels distal to proximal, stretch skin to make the vessel stand out, no pulse overlap, no double-pulsing on Nd:YAG, aggressive post-cooling; endpoint is vasoconstriction, vasospasm, or darkening of vessel contents — purpura usually resolves within 14 days. Pigmented: endpoint is erythema and edema around the lesion with no whitening; lesions darken then fade. Toning: endpoint is mild erythema and edema; float the I or O tip 0.5 inch above the skin. Combined vascular + toning in one session: treat the vessel first, cool, then tone.
Internal staff reference — not a substitute for the Operator's Manual (P/N 4100172100) or physician judgment. Final settings are always the treating provider's decision after in-person examination and a test spot.
Titration & comfort — the key rules: Temperature 38–43 °C is the working range (no pain, moderate warmth); ≥ 44 °C indicates heat accumulation from overlap or poor tip contact — output cuts off above 43 °C. Pain must not exceed 5/10 — more pain does NOT mean a more effective treatment. If no tissue response, raise the energy by exactly one level. Comfort ladder, in order: 1. confirm full tip contact → 2. increase ICD level → 3. switch to sliding technique → 4. adjust depth setting → 5. reduce energy level.
1. Depth modes
2. Starting levels by tip & depth
3. Starting levels by tissue type
4. Treatment protocols
5. EFFECTOR tip reference — all tips are single-use, discard after each patient
6. Device controls
Treatment workflow — setup
Attach the patient return pad to a flat, muscular area near the treatment site (upper or lower back) — single-use, discard after each patient. Mount the EFFECTOR tip and confirm tip type and shot count on the GUI; disinfect before use — tips ship non-sterile. Set depth, energy level, ICD level, interval, and switch type. Apply a thin coating of ultrasound gel — never treat dry tissue; reapply as the gel absorbs. Match impedance: press Ready, touch the tip lightly to the skin, and fire once; repeat if synchronization fails. Wear medical gloves. Treat the full area, adjusting level, depth, and ICD as needed. Remove gel when finished.
Technique
Stamping — no handpiece movement during each shot; preferred for most of the treatment. Sliding — move the tip one tip-width in a vector direction during a single shot; use on sensitive areas where pain is pronounced. Never stack shots (100% overlap) — keep overlap between rows at 30% or less; stacking causes rapid surface heat accumulation, discomfort, and adverse effects. Firm, even pressure is required for proper tissue contact. Over bony prominences, pinch the surrounding skin to stabilise tip contact — bony areas are more pain-sensitive. Avoid treating over areas with coarse hair, such as beard hair.
Internal staff reference — not a substitute for the Operator's Manual (P/N 4100194000) or physician judgment. Final settings are always the treating provider's decision after in-person examination.
Before Your Treatment
Medications to review before laser treatments
Some medications and products make skin more light-sensitive or affect healing, which can raise the risk of burns, blistering, or pigment changes with laser and IPL treatments. Share your complete medication and supplement list with your provider — typical hold times below are general ranges; your provider sets the actual plan.
Never stop a prescription medication on your own. Blood thinners, antibiotics, mood medications, and others can be dangerous to stop abruptly. Any hold must be approved by the doctor who prescribed it.
🔴 Oral isotretinoin (Accutane®)
Often 6 months
Isotretinoin (Accutane, Claravis, Absorica) — historically held ~6 months before ablative or resurfacing lasers due to healing and scarring concerns.
Some newer guidelines are less strict for certain non-ablative treatments — this is specifically a decision for your treating physician.
Oral retinoids other than isotretinoin — e.g., acitretin
If the medication treats an ongoing condition (blood pressure, heart rhythm, active infection), the prescriber decides whether a hold is safe — often the treatment is rescheduled instead.
Aspirin and NSAIDs — ibuprofen (Advil), naproxen (Aleve) — sometimes held ~1 week for bruise-prone procedures
Supplements that thin blood — fish oil/omega-3, vitamin E, ginkgo biloba, garlic, ginseng
Prescription anticoagulants — warfarin (Coumadin), apixaban (Eliquis), rivaroxaban (Xarelto), clopidogrel (Plavix) — do not stop; your provider will plan around them
🌿 Herbal & other photosensitizers
Commonly 1–2 weeks
St. John's Wort — significantly photosensitizing; taper only with prescriber guidance if used for mood
Gold therapy (historic rheumatoid arthritis treatment) — can cause permanent gray discoloration with laser/IPL; tell your provider if you've ever received it
💬 Also tell your provider about
Always disclose
History of cold sores — facial treatments may need antiviral prophylaxis (e.g., valacyclovir)
Pregnancy or breastfeeding — most cosmetic laser treatments are deferred
Recent sun, tanning bed, or self-tanner use on the treatment area
Keloid or abnormal scarring history
Recent fillers, Botox, or chemical peels in the treatment area
This guide is educational and not exhaustive; hold times vary by procedure, device, and patient. It is not medical advice. Decisions about starting, stopping, or holding any medication belong to you and your prescribing clinician together with your laser provider.
Skin Assessment Suite
